Literature DB >> 29958866

Severe community-acquired pneumonia due to Pseudomonas aeruginosa coinfection in an influenza A(H1N1)pdm09 patient.

I-Chia Su1, Kai-Ling Lee2, Hsin-Yi Liu3, Han-Chuan Chuang3, Li-Yuan Chen3, Yuarn-Jang Lee4.   

Abstract

Coinfection with Pseudomonas aeruginosa in patients with influenza is rare. Herein, we report a 39-year-old female patient who presented with severe community-acquired pneumonia due to coinfection with influenza A(H1N1)pdm09 and P. aeruginosa, which progressed to multifocal pneumonia with a fatal outcome.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Coinfection; Influenza A(H1N1)pdm09; Pneumonia; Pseudomonas aeruginosa

Mesh：

Year:  2018        PMID： 29958866     DOI： 10.1016/j.jmii.2018.05.007

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN： 1684-1182            Impact factor:   4.399


  12 in total

1.  Bacterial coinfection in influenza pneumonia: Rates, pathogens, and outcomes.

Authors:  Patricia S Bartley; Abhishek Deshpande; Pei-Chun Yu; Michael Klompas; Sarah D Haessler; Peter B Imrey; Marya D Zilberberg; Michael B Rothberg
Journal:  Infect Control Hosp Epidemiol       Date:  2021-04-23       Impact factor: 6.520

2.  Severe Pneumonia Caused by Coinfection With Influenza Virus Followed by Methicillin-Resistant Staphylococcus aureus Induces Higher Mortality in Mice.

Authors:  Leili Jia; Jiangyun Zhao; Chaojie Yang; Yuan Liang; Pengwei Long; Xiao Liu; Shaofu Qiu; Ligui Wang; Jing Xie; Hao Li; Hongbo Liu; Weiguang Guo; Shan Wang; Peng Li; Binghua Zhu; Rongzhang Hao; Hui Ma; Yong Jiang; Hongbin Song
Journal:  Front Immunol       Date:  2019-01-30       Impact factor: 7.561

3.  Performance of a multiplex PCR pneumonia panel for the identification of respiratory pathogens and the main determinants of resistance from the lower respiratory tract specimens of adult patients in intensive care units.

Authors:  Sze Hwei Lee; Sheng-Yuan Ruan; Sung-Ching Pan; Tai-Fen Lee; Jung-Yien Chien; Po-Ren Hsueh
Journal:  J Microbiol Immunol Infect       Date:  2019-11-23       Impact factor: 4.399

Review 4.  Induction of Trained Immunity by Recombinant Vaccines.

Authors:  Camila Covián; Mariana Ríos; Roslye V Berríos-Rojas; Susan M Bueno; Alexis M Kalergis
Journal:  Front Immunol       Date:  2021-01-07       Impact factor: 7.561

5.  Persistent Bacterial Coinfection of a COVID-19 Patient Caused by a Genetically Adapted Pseudomonas aeruginosa Chronic Colonizer.

Authors:  Jiuxin Qu; Zhao Cai; Yumei Liu; Xiangke Duan; Shuhong Han; Jihong Liu; Yuao Zhu; Zhaofang Jiang; Yingdan Zhang; Chao Zhuo; Yang Liu; Yingxia Liu; Lei Liu; Liang Yang
Journal:  Front Cell Infect Microbiol       Date:  2021-03-17       Impact factor: 5.293

6.  Carbon-Based Nanomaterials: Promising Antiviral Agents to Combat COVID-19 in the Microbial-Resistant Era.

Authors:  Ángel Serrano-Aroca; Kazuo Takayama; Alberto Tuñón-Molina; Murat Seyran; Sk Sarif Hassan; Pabitra Pal Choudhury; Vladimir N Uversky; Kenneth Lundstrom; Parise Adadi; Giorgio Palù; Alaa A A Aljabali; Gaurav Chauhan; Ramesh Kandimalla; Murtaza M Tambuwala; Amos Lal; Tarek Mohamed Abd El-Aziz; Samendra Sherchan; Debmalya Barh; Elrashdy M Redwan; Nicolas G Bazan; Yogendra Kumar Mishra; Bruce D Uhal; Adam Brufsky
Journal:  ACS Nano       Date:  2021-04-07       Impact factor: 15.881

7.  Non-Woven Infection Prevention Fabrics Coated with Biobased Cranberry Extracts Inactivate Enveloped Viruses Such as SARS-CoV-2 and Multidrug-Resistant Bacteria.

Authors:  Kazuo Takayama; Alberto Tuñón-Molina; Alba Cano-Vicent; Yukiko Muramoto; Takeshi Noda; José Luis Aparicio-Collado; Roser Sabater I Serra; Miguel Martí; Ángel Serrano-Aroca
Journal:  Int J Mol Sci       Date:  2021-11-24       Impact factor: 5.923

Review 8.  An updated min-review on environmental route of the SARS-CoV-2 transmission.

Authors:  Edris Hoseinzadeh; Mahdi Farzadkia; Farshid Mohammadi; Hooshyar Hossini; Mahmoud Taghavi
Journal:  Ecotoxicol Environ Saf       Date:  2020-07-09       Impact factor: 6.291

9.  Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges.

Authors:  Chih-Cheng Lai; Tzu-Ping Shih; Wen-Chien Ko; Hung-Jen Tang; Po-Ren Hsueh
Journal:  Int J Antimicrob Agents       Date:  2020-02-17       Impact factor: 5.283

Review 10.  Bacterial co-infections with SARS-CoV-2.

Authors:  Rasoul Mirzaei; Pedram Goodarzi; Muhammad Asadi; Ayda Soltani; Hussain Ali Abraham Aljanabi; Ali Salimi Jeda; Shirin Dashtbin; Saba Jalalifar; Rokhsareh Mohammadzadeh; Ali Teimoori; Kamran Tari; Mehdi Salari; Sima Ghiasvand; Sima Kazemi; Rasoul Yousefimashouf; Hossein Keyvani; Sajad Karampoor
Journal:  IUBMB Life       Date:  2020-08-08       Impact factor: 4.709
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.